Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7257)
All Articles published online
|
Publishing Process of This Article
|
Dec 14, 2016 (publication date) through Dec 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pedersen MR, Patel A, Backstedt D, Choi M, Seetharam AB. Genotype specific peripheral lipid profile changes with hepatitis C therapy. World J Gastroenterol 2016; 22(46): 10226-10231 [PMID: 28028371 DOI: 10.3748/wjg.v22.i46.10226] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v22/i46/10226.htm |
| Number | Citing Articles |
| 1 |
Szu-Jen Wang, Chung-Feng Huang, Ming-Lung Yu. Elbasvir and grazoprevir for the treatment of hepatitis C. Expert Review of Anti-infective Therapy 2021; 19(9): 1071 doi: 10.1080/14787210.2021.1874351
|
| 2 |
Vanessa Gutierrez de ANDRADE, Fabio da Silva YAMASHIRO, Cassio Vieira OLIVEIRA, Leticia Lastória KUROZAWA, Alecsandro MOREIRA, Giovanni Faria SILVA. INCREASE OF LIPIDS DURING HCV TREATMENT: VIRUS ACTION OR MEDICATION?. Arquivos de Gastroenterologia 2018; 55(2): 184 doi: 10.1590/s0004-2803.201800000-33
|
| 3 |
Chung‐Feng Huang, Chia‐Yen Dai, Ming‐Lun Yeh, Ching‐I Huang, Hsiang‐Chun Lee, Wen‐Ter Lai, Po‐Cheng Liang, Yi‐Hung Lin, Ming‐Yen Hsieh, Nai‐Jen Hou, Zu‐Yau Lin, Shinn‐Cherng Chen, Jee‐Fu Huang, Wan‐Long Chuang, Ming‐Lung Yu. Cure or curd: Modification of lipid profiles and cardio‐cerebrovascular events after hepatitis C virus eradication. The Kaohsiung Journal of Medical Sciences 2020; 36(11): 920 doi: 10.1002/kjm2.12275
|
| 4 |
Matt Driedger, Chrissi Galanakis, Mary-Anne Doyle, Curtis L. Cooper. Direct-acting antiviral hepatitis C virus treatment perturbation of the metabolic milieu. European Journal of Gastroenterology & Hepatology 2019; 31(2): 260 doi: 10.1097/MEG.0000000000001292
|
| 5 |
H. A. Elmekawy, F. Belal, A. E. Abdelaziz, K. S. Abdelkawy, A. A. Ali, F. Elbarbry. Pharmacokinetic interaction between atorvastatin and fixed-dose combination of sofosbuvir/ledipasvir in healthy male Egyptian volunteers. European Journal of Clinical Pharmacology 2021; 77(9): 1369 doi: 10.1007/s00228-021-03130-z
|
| 6 |
Marcus Höring, Georg Peschel, Jonathan Grimm, Sabrina Krautbauer, Martina Müller, Kilian Weigand, Gerhard Liebisch, Christa Buechler. Serum Ceramide Species Are Associated with Liver Cirrhosis and Viral Genotype in Patients with Hepatitis C Infection. International Journal of Molecular Sciences 2022; 23(17): 9806 doi: 10.3390/ijms23179806
|
| 7 |
Thomas Grewal, Christa Buechler. Emerging Insights on the Diverse Roles of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Chronic Liver Diseases: Cholesterol Metabolism and Beyond. International Journal of Molecular Sciences 2022; 23(3): 1070 doi: 10.3390/ijms23031070
|
| 8 |
Ying-Wen Wang, Wei-Ping Lee, Yi-Hsiang Huang, Ming-Chih Hou, Keng-Hsin Lan. Effect of sofosbuvir-based DAAs on changes in lower-density lipoprotein in HCV patients: a systematic review and meta-analysis. BMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-06657-9
|
| 9 |
Ken Sato, Yuki Kanayama, Yuichi Yamazaki, Hiroki Tojima, Takayoshi Suga, Daisuke Uehara, Satoru Kakizaki, Kunio Yanagisawa, Toshio Uraoka, Hiroshi Ohnishi, Hiroaki Okamoto. Successful treatment of Japanese hemophilia patient co-infected with HIV and HCV genotype 4a by glecaprevir/pibrentasvir therapy. Clinical Journal of Gastroenterology 2021; 14(6): 1725 doi: 10.1007/s12328-021-01524-1
|
| 10 |
Yi-Kai Wang, Ying-Wen Wang, Chia-Ling Lu, Yi-Hsiang Huang, Ming-Chih Hou, Yuh-Lih Chang, Wei-Ping Lee, Keng-Hsin Lan. Sofosbuvir-based direct-acting antivirals and changes in cholesterol and low density lipoprotein-cholesterol. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-13657-5
|
| 11 |
Tingting Mei, Xiaojie Huang, Shan Tang, Menglu Liu, Wenyan Zhang, Haibin Yu. Effects of sustained viral response on lipid in Hepatitis C: a systematic review and meta-analysis. Lipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-023-01957-2
|
| 12 |
Andrea Dalbeni, Rosanna Villani, Michele Bevilacqua, Federica Sacco, Diego Faccincani, Filippo Cattazzo, Francesco Cavallone, Anna Mantovani, Vittoria Ceruti, Donatella Ieluzzi, Veronica Paon, Alessandro Mantovani, Gaetano Serviddio, David Sacerdoti. Effects of direct‐acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real‐life Italian experience. Journal of Digestive Diseases 2022; 23(5-6): 324 doi: 10.1111/1751-2980.13103
|